• OPEN AN ACCOUNT
Indian Indices
Sensex
74,858.99 564.03
( 0.76%)
Global Indices
Nasdaq
51,699.28 -99.76
(-0.19%)
Dow Jones
7,668.45 9.69
(0.13%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,737.46 78.33
(0.73%)
Forex
USD-INR
95.87 0.21
(0.22%)
EUR-INR
110.00 -0.22
(-0.20%)
GBP-INR
128.18 -0.44
(-0.35%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
477.507017
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
16.34
14577.75
EPS(TTM)
Face Value()
Div & Yield %
49.8
2
0.61
 

gee ltd
Veejay Lakshmi Engineering Works reports consolidated net loss of Rs 0.35 crore in the March 2026 quarter
May 29,2026
Net Loss of Veejay Lakshmi Engineering Works reported to Rs 0.35 crore in the quarter ended March 2026 as against net loss of Rs 1.42 crore during the previous quarter ended March 2025. Sales rose 36.59% to Rs 24.45 crore in the quarter ended March 2026 as against Rs 17.90 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 5.47 crore in the year ended March 2026 as against net loss of Rs 3.29 crore during the previous year ended March 2025. Sales rose 0.73% to Rs 80.23 crore in the year ended March 2026 as against Rs 79.65 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales24.4517.90 37 80.2379.65 1
OPM %-0.86-4.64 --5.85-1.90 -
PBDT0.41-0.71 LP -2.93-0.81 -262
PBT-0.20-1.39 86 -5.43-3.30 -65
NP-0.35-1.42 75 -5.47-3.29 -66